D
Douglas N. Fish
Researcher at University of Montana
Publications - 156
Citations - 9782
Douglas N. Fish is an academic researcher from University of Montana. The author has contributed to research in topics: Intensive care & Cefepime. The author has an hindex of 42, co-authored 152 publications receiving 8684 citations. Previous affiliations of Douglas N. Fish include University of Illinois at Urbana–Champaign & University of Colorado Boulder.
Papers
More filters
Journal ArticleDOI
Clinical practice guidelines for antimicrobial prophylaxis in surgery
Dale W. Bratzler,E. Patchen Dellinger,Keith M. Olsen,Trish M. Perl,Paul G. Auwaerter,Maureen K. Bolon,Douglas N. Fish,Douglas N. Fish,Lena M. Napolitano,Robert G. Sawyer,Douglas Slain,James P. Steinberg,Robert A. Weinstein +12 more
TL;DR: These guidelines were developed jointly by the American Society of Health-System Pharmacists (ASHP), the Infectious Diseases Society of America, the Surgical Infection Society (SIS), and the Society for Healthcare Epidemiology of America (SHEA).
Journal ArticleDOI
Clinical practice guidelines for antimicrobial prophylaxis in surgery.
Dale W. Bratzler,E. Patchen Dellinger,Keith M. Olsen,Trish M. Perl,Paul G. Auwaerter,Maureen K. Bolon,Douglas N. Fish,Douglas N. Fish,Lena M. Napolitano,Robert G. Sawyer,Douglas Slain,James P. Steinberg,Robert A. Weinstein +12 more
TL;DR: The guidelines were developed jointly by the American Society of Health-System Pharmacists (ASHP), the Infectious Diseases Society of America (IDSA), the Surgical Infection Society (SIS), and the Society for Healthcare Epidemiology (SHEA) as mentioned in this paper.
Journal ArticleDOI
Ispd peritonitis recommendations: 2016 update on prevention and treatment
Philip Kam-Tao Li,Cheuk-Chun Szeto,Beth Piraino,Javier de Arteaga,Stanley Fan,Ana Elizabeth Figueiredo,Douglas N. Fish,Eric Goffin,Yong-Lim Kim,William Salzer,Dirk G. Struijk,Isaac Teitelbaum,David W. Johnson +12 more
TL;DR: Recommendations under the auspices of the International Society for Peritoneal Dialysis (ISPD) were first published in 1983 and revised in 1993, 1996, 2000, 2005, and 2010 are revised.
Journal ArticleDOI
The clinical pharmacokinetics of levofloxacin.
Douglas N. Fish,Andrew T. Chow +1 more
TL;DR: Levofloxacin appears to have only minor potential for significantly altering the pharmacokinetics of theophylline, warfarin, zidovudine, ranitidine, digoxin or cyclosporin; however, patients receiving these drugs concurrently should be monitored closely for signs of enhanced pharmacological effect or toxicity.
Journal ArticleDOI
Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.
TL;DR: Patients with severe MDRPA infections should be treated with combination therapy, consisting of an antipseudomonal β‐lactam with an aminoglycoside or fluoroquinolone rather than aminglycoside and fluoroquolone combinations, to provide adequate therapy and improve patient outcomes.